Funding · Agriculture & Food Systems
ELMED Life Sciences raises $2.7 million Series A
By Startup Enthusiast ·
- Date
- Company
- ELMED Life Sciences
- What it does
- Probiotic and biological solutions provider
- Kind
- Funding
- Amount
- $2.7 million (₹25 crore)
- Stage
- Series A
- Based in
- Hyderabad
- Founded
- 2018
What they do
ELMED makes probiotic-based solutions for animal health, agriculture, aquaculture and human health
What happened
It raised $2.7 million in Series A funding from AgriSURE Fund, managed by NABVENTURES
Why it matters
The company is the first in India to develop probiotics specifically for agriculture
The details
- ELMED Life Sciences raised $2.7 million (₹25 crore) in Series A funding.
- The round was led by AgriSURE Fund, managed by NABVENTURES, the venture capital arm of NABARD.
- The company will use the funds to expand manufacturing in Hyderabad.
- It will also strengthen R&D in microbiome-based solutions.
- ELMED plans to scale distribution across Tier 2 and Tier 3 Indian markets.
- It aims to build presence in international markets like Europe, Asia and LATAM.
- The company focuses on a ONE HEALTH approach, linking human, animal and environmental health.
The bigger picture
- Global and Indian agriculture is shifting to biological and microbiome-based solutions due to antibiotic restrictions and export standards.
- The Indian probiotic segment in animal health, aquaculture and agriculture is growing rapidly.
- Investor interest in microbiome solutions is picking up, with examples like The Good Bug raising ₹100 crore and GreenGrahi raising ₹32 crore.
About the business
- ELMED is a science-led company offering probiotic and biological solutions across animal health, aquaculture, agriculture and human health.
- Its products include probiotic-based solutions for poultry, dairy, livestock, shrimp, fish farming and soil/plant health.
- It offers contract manufacturing and R&D services to global healthcare and agri-biotech companies.
- Top clients include Xanum, Hetero Healthcare, Wallace Pharmaceuticals and Donovan.
- Its facility in Hyderabad produces probiotics in oral suspensions, emulsions, drops, capsules, sachets and syrups for humans, aquatic life, animals and plants.
- ELMED is the first company in India to research and develop probiotics specifically for agriculture.
- It follows a B2B approach and serves multiple notable MNCs.
- The company exports to more than 18 countries.
What happens next
- Expand manufacturing capacity in Hyderabad.
- Strengthen R&D in microbiome-based solutions.
- Scale distribution across Tier 2 and Tier 3 Indian markets.
- Build presence in international markets including Europe, Asia and LATAM.
- Focus on the ONE HEALTH approach.
The deal
- Type
- Series A
Investors
- AgriSURE Fund (lead) — AgriSURE Fund is managed by NABVENTURES, the venture capital arm of NABARD.
Founders
- Pruthivin Reddy Madduri, Founder & Managing Director
- Nikhil Konkathi, Co-founder
About ELMED Life Sciences
- Product
- Probiotic and microbiome-based biological solutions for poultry, dairy, livestock, aquaculture, and soil health
- Customers
- Enterprise clients in animal agriculture, aquaculture, and sustainable farming sectors
- How it makes money
- B2B biotech manufacturer supplying probiotics to pharma companies and agricultural enterprises
- What sets it apart
- Microbiome-based solutions supporting antibiotic-free and sustainable practices in agriculture
Other articles talking about it
Same day
- Burma Burma raises Rs 38 crore to expand across India25 March 2026 · Funding · Rs 38 crore ($4 million)
- Rocketlane raises $60m in series c funding led by insight partners25 March 2026 · Funding · $60M
- Go Digit gets ₹384.4 crore income tax demand25 March 2026 · Policy
- Skyroot Aerospace raises Rs 100 crore debt from BlackRock25 March 2026 · Funding · Rs 100 crore
- Canvaloop raises $1.5 million to scale sustainable fibre production25 March 2026 · Funding · $1.5M
- Dream Sports pivots to fintech after gaming ban25 March 2026 · Pivot